Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin and S. Baicalensis Combination Therapy in Type 2 Diabetes
NCT02844803Phase 1Unknown
- Start
- Jul 2016
- Primary completion
- Jun 2017
- Modality
- PE (Plant Extract)
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of Huangling Gel in type 2 diabetes mellitus (T2DM) (2 arms). Primary endpoint: Change of serum glucose level after 8 weeks from baseline. Status: unknown.
02
Drugs
Huangling Gel
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02844803.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02844803.